A recording of the ASX:EXL Q4 FY25 Results & Outlook Webinar is now available!
Click here to view the recording
Across Markets…
The Australian sharemarket fell on Friday as fears of AI-driven overinvestment and disruption to software companies triggered broad selling.
The S&P/ASX 200 Index dropped 125.90 points, or 1.4 per cent, to 8917.60, with nine of the 11 sectors lower. The benchmark gained 2.4 per cent for the week.
Concerns that AI could erode software companies’ margins have seen the ASX tech sector shed 23 per cent of its value over the past month. WiseTech Global fell 10.4 per cent to $42.62 on Friday, Xero by 4.5 per cent to $73.49, and TechnologyOne 7.1 per cent to $20.17.
Morningstar market strategist Lochlan Halloway said the so-called “SaaSpocalypse” has been building for months, with AI threatening every variable in the SaaS model: seats, modules, and price.
“Some software companies, particularly those selling commoditised tools with shallow integrations, face a genuine existential threat,” he said. “If one person can now do the work of two, seat counts fall… And if the price of ‘work’ collapses, so too could the value of a software vendor’s product.”
Gold recovered some losses to just under $US5000 an ounce after a sharp sell-off in the previous session, as dip-buyers snapped up the metal ahead of key US inflation data. Northern Star fell 3.5 per cent to $28.37, Newmont 1.9 per cent to $169.12, and Genesis Minerals 4.6 per cent to $6.87.
Banks saw profit-taking after recent gains. Commonwealth Bank dropped 1.4 per cent to $176.20, National Australia Bank 1.1 per cent to $46.01, and Westpac 1.2 per cent to $40.52, as its net interest margin shrank despite a better-than-expected $1.9 billion profit. ANZ rose 1.3 per cent to $40.89 after a Morgan Stanley upgrade, while AMP jumped 9 per cent to $1.39 following its biggest rebound in over 20 years.
Source: AFR
Felix Gold Reports Promising Gold Mineralisation Extension as Antimony Production Strategy Advances
Felix Gold (ASX: FXG) has announced a significant westward extension of gold mineralisation at its NW Array drilling, with multiple high-grade intersections.
This discovery coincides with the company’s strategic pivot and ongoing efforts towards near-term antimony production in Alaska.
Trenching at NW Array exposed 67m of gold mineralisation across a 90m trench, located 130m west of the main 2025 drilling area.
The best trench sub-interval revealed 12m at 2.86 g/t Au within a 26m interval grading 1.86 g/t Au (from 46–72m).
NW Array Gold Mineralisation
Drilling results also returned impressive gold intersections, including 15.71m at 2.91 g/t Au from 37.61m (hole 25TCDC004), which contained 11.01m at 3.87 g/t Au.
Another notable intercept was 13.72m at 2.83 g/t Au from 27.43m (hole 25TCRC003), including 7.62m at 4.45 g/t Au. Additionally, hole 25TCDC020 intersected 47.36m at 1.34 g/t Au from 19.5m.
The company noted that mineralisation remains open along strike and at depth, indicating further exploration potential at Treasure Creek.
Significant gold assay results are still pending for 44 diamond holes and 18 reverse circulation (RC) holes, with antimony and multi-element assays pending for 45 diamond holes and 6 RC holes.
Dual Commodity Strategy Advances
The confirmed gold mineralisation at NW Array forms halos around antimony veins, supporting Felix Gold’s dual commodity approach.
This means that both valuable minerals are found within the same geological structures, offering synergistic development opportunities.
The NW Array area is part of the broader Fairbanks district, where Felix Gold is the largest landholder.
The company boasts a substantial 831,000 oz JORC inferred gold resource across its regional holdings.
This resource is located approximately 30 km from the Kinross Fort Knox mill, offering potential future processing optionality.
Antimony Production Pathway
Felix Gold continues to strategically pivot towards near-term antimony production at its Treasure Creek project in Alaska.
This pivot has been driven by the critical mineral status of antimony and global supply dynamics.
Recent metallurgical test work has achieved a significant breakthrough, demonstrating the ability to produce military-grade antimony concentrate from domestic ore.
The company has secured exclusive rights to the Albion Process for its project.
A pilot plant program is currently underway, with approximately 300 kg of massive stibnite ore sent to Core Technologies for testing.
Felix Gold aims for toll treatment to commence in the second half of 2026 or to establish a dedicated smelter in the first half of 2027, accelerating the pathway to first metal production.
The company has also indicated significant interest from the US Department of Energy (DOE) for funding, with two applications totalling over 80 million USD.
To read more, click here
Source: SmallCaps
Company: Fin Resources Ltd (ASX:FIN)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.0065
Performance Since Entry: +100%
Company: Locksley Resources Ltd (ASX:LKY)
Sector: REE & Antimony/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +338%
Company: CuFe Ltd (ASX:CUF)
Sector: Copper/Mining
Deal Type: Placement
Latest Entry Price: $0.016 with 1:2 option, strike $0.025
Price Performance Since Entry: +225%
Company: Tasman Resources Ltd (ASX:TAS)
Sector: Gold/Silver/Mining
Deal Type: Placement
Latest Entry Price: $0.0125 with 1:2 option, strike $0.02
Price Performance Since Entry: +436%
Company: Tambourah Metals Ltd (ASX:TMB)=
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Price Performance Since Entry: +38%
Company: Biotron Ltd (ASX:BIT)
Sector: Biotech
Deal Type: Placement
Latest Entry Price: $0.003 with 1:2 option, strike $0.02
Price Performance Since Entry: 0%
Company: Eclipse Metals Ltd (ASX:EPM)
Sector: REE
Deal Type: Placement
Latest Entry Price: $0.015
Price Performance Since Entry: +47%
Company: Neuren Pharmaceuticals Ltd (ASX:NEU)
Sector: Biotech
Deal Type: On-market purchase
Latest Entry Price: $1.20 – $1.50
Price Performance Since Entry: +1,115%
Company: Dimerix Ltd (ASX:DXB)
Sector: Biotech
Deal Type: Rights Issue
Raise Amount: $800,000
Latest Entry Price: $0.08 with 1:1 option, strike $0.126
Price Performance Since Entry: $0.505 +494%
Sector: Blockchain
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.02 with 1:1 option $0.08 strike
Price Performance Since Entry: +45%
Company: Critica Limited (ASX:CRI)
Sector: REE
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.0075 with a 1:1 CRIO
Price Performance Since Entry: +273%
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.09 with 1:2 PL3O
Price Performance Since Entry: +67%
Sector: Gold/Mining
Deal Type: Placement
Raise Amount: $2.3M
Latest Entry Price: $0.026 with 1:2 option $0.032 strike
Price Performance Since Entry: +85%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
Comments are closed